TScan Therapeutics, Inc. - TCRX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$665M
QoQ value delta ($000)
+$4.951M (+0.75%)
Implied price effect (QoQ)
-12.48%
Shares
Total shares
35,333,581
QoQ shares delta
+4,639,603 (+15.12%)
Total shares held by funds (by quarter)

Market chart (TCRX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 60 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
DC Funds, LP 630,000 630,000 42.4%
Lynx1 Capital Management LP 8,099 8,019,148 1.28%
BVF INC/IL 5,619 5,564,290 0.18%
BAKER BROS. ADVISORS LP 2,812 2,784,792 0.02%
VANGUARD GROUP INC 2,475 2,475,733 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 2,175 2,154,256 0.0%
BlackRock, Inc. 1,859 1,840,952 0.0%
MILLENNIUM MANAGEMENT LLC 1,474 1,460,285 0.0%
RENAISSANCE TECHNOLOGIES LLC 1,378 1,364,783 0.0%
Deer Management Co. LLC 1,257 1,245,504 0.2%
TWO SIGMA INVESTMENTS, LP 1,221 1,209,009 0.0%
Aberdeen Group plc 927 918,020 0.0%
JACOBS LEVY EQUITY MANAGEMENT, INC 816 808,356 0.0%
GEODE CAPITAL MANAGEMENT, LLC 623 616,952 0.0%
GSA CAPITAL PARTNERS LLP 383 378,960 0.02%
TWO SIGMA ADVISERS, LP 353 353,900 0.0%
D. E. Shaw & Co., Inc. 322 319,587 0.0%
CITADEL ADVISORS LLC 321 318,411 0.0%
VANGUARD FIDUCIARY TRUST CO 308 305,772 0.0%
MARSHALL WACE, LLP 239 237,346 0.0%
STATE STREET CORP 209 207,313 0.0%
ACADIAN ASSET MANAGEMENT LLC 201 201,987 0.0%
MORGAN STANLEY 175 173,643 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 158 157,228 0.0%
JANE STREET GROUP, LLC 145 144,421 0.0%